Education
About Us
Working with TipRanks
Follow Us
Tenet Healthcare (THC)
NYSE:THC
THC Analyst Ratings
Strong Buy
16 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
THC Stock 12 Month Forecast
Average Price Target
$235.06
▲(16.72% Upside)
| Highest Price Target$260.00 | Average Price Target$235.06 | Lowest Price Target$190.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
$225→$235
Buy
16.69%
Upside
Reiterated
11/03/25
Truist Financial
$225→$240
Buy
19.17%
Upside
Reiterated
11/03/25
Jefferies
$250
Buy
24.14%
Upside
Reiterated
10/31/25
Raymond James
$200→$250
Buy
24.14%
Upside
Reiterated
10/29/25
Tenet Healthcare: Strong Performance and Positive Outlook Drive Buy RatingWe reiterate our Outperform rating on shares of THC while raising our price target to $250 (~8.5x 2027 EBITDA ex-NCI) following 3Q25 results that exceeded expectations as the company reported adj. EBITDA of $1,099M (Street: $1,035M, RJ: $1,035M), and adj. EBITDA ex-NCI of $862M (RJ: $801M). The quarter did benefit from a $38M out of period DPP, so the core beat was closer to ~$23M all attributable to the hospital division. The quarter, in total, benefited from $346M of supplemental payments.
UBS
$238→$260
Buy
29.10%
Upside
Reiterated
10/29/25
RBC Capital
$230→$252
Buy
25.13%
Upside
Reiterated
10/29/25
Morgan Stanley
$225→$232
Buy
15.20%
Upside
Reiterated
10/29/25
TR | OpenAI - 4o
$226→$228
Buy
13.21%
Upside
Reiterated
10/29/25
AI Generated ArticleAI Generated Article
TD Cowen
$192→$233
Buy
15.70%
Upside
Reiterated
10/29/25
Bank of America Securities
$225→$230
Buy
14.21%
Upside
Reiterated
10/28/25
Guggenheim
$221→$238
Buy
18.18%
Upside
Reiterated
10/28/25
Leerink Partners
$235
Buy
16.69%
Upside
Reiterated
10/22/25
Goldman Sachs
$169→$224
Buy
11.23%
Upside
Reiterated
10/15/25
Barclays
$229
Buy
13.71%
Upside
Reiterated
10/09/25
KeyBanc
$205→$225
Buy
11.72%
Upside
Reiterated
10/08/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
$225→$235
Buy
16.69%
Upside
Reiterated
11/03/25
Truist Financial
$225→$240
Buy
19.17%
Upside
Reiterated
11/03/25
Jefferies
$250
Buy
24.14%
Upside
Reiterated
10/31/25
Raymond James
$200→$250
Buy
24.14%
Upside
Reiterated
10/29/25
Tenet Healthcare: Strong Performance and Positive Outlook Drive Buy RatingWe reiterate our Outperform rating on shares of THC while raising our price target to $250 (~8.5x 2027 EBITDA ex-NCI) following 3Q25 results that exceeded expectations as the company reported adj. EBITDA of $1,099M (Street: $1,035M, RJ: $1,035M), and adj. EBITDA ex-NCI of $862M (RJ: $801M). The quarter did benefit from a $38M out of period DPP, so the core beat was closer to ~$23M all attributable to the hospital division. The quarter, in total, benefited from $346M of supplemental payments.
UBS
$238→$260
Buy
29.10%
Upside
Reiterated
10/29/25
RBC Capital
$230→$252
Buy
25.13%
Upside
Reiterated
10/29/25
Morgan Stanley
$225→$232
Buy
15.20%
Upside
Reiterated
10/29/25
TR | OpenAI - 4o
$226→$228
Buy
13.21%
Upside
Reiterated
10/29/25
AI Generated ArticleAI Generated Article
TD Cowen
$192→$233
Buy
15.70%
Upside
Reiterated
10/29/25
Bank of America Securities
$225→$230
Buy
14.21%
Upside
Reiterated
10/28/25
Guggenheim
$221→$238
Buy
18.18%
Upside
Reiterated
10/28/25
Leerink Partners
$235
Buy
16.69%
Upside
Reiterated
10/22/25
Goldman Sachs
$169→$224
Buy
11.23%
Upside
Reiterated
10/15/25
Barclays
$229
Buy
13.71%
Upside
Reiterated
10/09/25
KeyBanc
$205→$225
Buy
11.72%
Upside
Reiterated
10/08/25
Best Analysts Covering Tenet Healthcare
1 Month
xxx
Success Rate
18/23 ratings generated profit
Average Return
+8.08%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 78.26% of your transactions generating a profit, with an average return of +8.08% per trade.
3 Months
xxx
Success Rate
17/22 ratings generated profit
Average Return
+8.78%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +8.78% per trade.
1 Year
Success Rate
21/23 ratings generated profit
Average Return
+36.80%
reiterated a buy rating 2 days ago
Copying David S Macdonald's trades and holding each position for 1 Year would result in 91.30% of your transactions generating a profit, with an average return of +36.80% per trade.
2 Years
xxx
Success Rate
23/23 ratings generated profit
Average Return
+84.84%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +84.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
THC Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
1
1
1
0
0
Buy
36
35
34
36
31
Hold
4
4
4
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
40
39
37
31
Each month's total comprises the sum of three months' worth of ratings.
THC Financial Forecast
THC Stock Forecast FAQ
What is THC’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 235.06.
What is THC’s upside potential, based on the analysts’ average price target?
Tenet Healthcare has 16.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is THC a Buy, Sell or Hold?
Tenet Healthcare has a consensus rating of Strong Buy which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
What is Tenet Healthcare’s price target?
The average price target for Tenet Healthcare is 235.06. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $260.00 ,the lowest forecast is $190.00. The average price target represents 16.72% Increase from the current price of $201.39.
The highest analyst price target is $260.00 ,the lowest forecast is $190.00. The average price target represents 16.72% Increase from the current price of $201.39.
What do analysts say about Tenet Healthcare?
Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of THC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.